Drugdiscovery >> Drugs >> News
3831
Views
We have too few resp on safety issues - drugdiscovery.com
We have too few resp on safety issues - drugdiscovery.com


Adverse reactions on certain drugs are usually go unpublished according to the blogger of HOOKED. There is a big silence about security warnings, which some cases means a big risk on the patient's side as well.
Read More >>


Tags: risk, regulation, drug, safety issues, dangerous drugs - February 6, 2014
Related Articles
5520
Views
Glaxo’s COPD drug safety questioned Glaxo’s COPD drug safety questioned
FDA reviewers question safety of Glaxo’s once-daily treatment for chronic obstructive pulmonary disease, Anoro Ellipta (umeclidinium/vilanterol). Read More >>

Tags: Anoro Ellipta, anoro ellipta, umeclidinium/vilanterol, Glaxo, FDA, COPD, drug, safety, umeclidinium, vilanterol

15516
Views
How Drugs are Developed and Approved How Drugs are Developed and Approved
In the United States, all medications except natural remedies and supplements, must go through an approval process before they can be made available to people. The Food and Drug Administration (FDA) i Read More >>

Tags: FDA, CDER, drug safety

4213
Views
In face of abuse epidemic, FDA restricts long-term opioid use In face of abuse epidemic, FDA restricts long-term opioid use
Aiming to combat abuse, the FDA announced that extended-release and long-acting (ER/LA) opioid pain relievers are no longer indicated for merely moderate pain, and orders new labeling and safety rules Read More >>

Tags: opioids, opioid painkillers, abuse, FDA, indications, new labeling, safety

4065
Views
No Revlimid for chronic lymphocytic leukemia No Revlimid for chronic lymphocytic leukemia
Due to significant safety concerns, FDA halts clinical trial of this drug for chronic lymphocytic leukemia in patients 65 years and older. Read More >>

Tags: Revlimid, lenalidomide, lymphocytic leukema, drug safety

7545
Views
No significant difference in tiotropium mist, powder safety and effectiveness No significant difference in tiotropium mist, powder safety and effectiveness
The results of a large study have shown that the new “mist” - Respimat inhaler, and traditional “dry powder” – HandiHaler have similar safety profile and effectiveness. Read More >>

Tags: tiotropium, respimat inhaler, respimat, handihaler, COPD, treatment, inhaler

7000
Views
Nizoral (ketoconazole) warning Nizoral (ketoconazole) warning
FDA has limited Nizoral oral tablets use due to potentially fatal liver injury and risk of drug interactions and adrenal gland problems. Read More >>

Tags: Nizoral, ketoconazole, liver injury, drug interactions, drug safety, adrenal gland problems

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013